Tag: venture capital
-
Infographic – Digital Health Venture Funds Remain Stuck
Global venture funding for digital health start-ups remains mired at low levels, as the number of investment deals in the second quarter of 2023 dropped to its lowest level in eight years.
-
Cancer Immunotherapy Biotech Issues $80M IPO
A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO.
-
Infographic – U.S. Life Science Venture Activity Keeps Falling
Investments in life science start-ups in the U.S. show continued declines into the second quarter of 2023, reaching levels not seen in four or five years.
-
Venture Fund to Back Life Science A.I. Start-Ups
A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field.
-
Infographic – Venture Funds Continue Slide in Q2
Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year.
-
Synthetic DNA Company Gains $10M in Venture Round
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round.
-
Weather Balloon Data Company Raises $6M in Seed Funds
A company creating a network of long-range high-altitude balloons to expand the scope of global weather forecasting is raising $6 million in seed funds.
-
Biotech Start-Up to Discover Cystic Fibrosis Therapy
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder.
-
Crop Health Device Company Raises $3.5M in Early Funds
A company detecting early-stage crop diseases with handheld devices and artificial intelligence is raising $3.5 million in its seed venture round.
-
Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds.